This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

Treat vitamin D deficiency to prevent deadly ... Vitamin D supplements have been found to reduce the risk of ... (13 Jan 2019)
Even moderate alcohol consumption is a risk ... A new study published in HeartRhythm reports that regular ... (13 Jan 2019)
Are Your Facebook Friends Making You Feel ... Research published in Heliyon finds that Facebook users who ... (13 Jan 2019)
High intake of dietary fibre and whole ...   High intake of dietary fibre and whole grains associated ... (13 Jan 2019)
Newborns Face Risks When Born to Women with ... Pregnant women with influenza are more likely to experience ... (11 Jan 2019)
Monday, 29 August 2016 00:00

Update on Avian Influenza

Written by
Rate this item
(0 votes)

by Tanya Melillo Fenech MD MSc
Principle Medical Officer at Infectious Disease Prevention and Control Unit
Department of Health Promotion and Disease Prevention

Study on environmental sampling during an Avian Outbreak in Cambodia

Samples were taken from the environment of households within one kilometre of the confirmed outbreak of birds or confirmed human cases. They sampled mud, still water (ponds), soil and water plants in and around 14 households areas in three villages with PCR testing. Viral RNA was detectable in poultry faeces, soil, some unconcentrated water, mud, water plants and feathers of dead poultry. However it was not possible to isolate any viruses so the role of environmental contaminants in infecting humans is so far still unclear. However it does reinforce the theory that those in contact with poultry and their detritus are at a potential risk of avian influenza and other zoonotic infections.

Update on Oseltamivir resistance in 2007-2008 seasonal influenza viruses in Europe

Although sporadic low level transmission of drug resistant viruses has  taken place since 1999 when the Neuraminidase inhibitor drugs were first licensed, it was the winter season 07/08 that for the first time showed widespread and sustained transmission of such viruses in the community. Such viruses previously had not been able to readily transmit and had rapidly disappeared.

The proportion of Influenza A (H1N1) viruses that were found to be oseltamivir resistant varied significantly across Europe. The highest proportion of resistant viruses to date has been in Norway followed by Belgium, France, Netherlands and Luxembourg. Surveillance in previous years by the Virgil Project found <1% of circulating viruses to be resistant. There is no evidence that the appearance of these new viruses are related to use of oseltamivir which is currently not widely prescribed in most European countries. The European Centre of Disease Prevention and Control (ECDC) is now working with the manufacturer and national authorities to gather more information on routine oseltamivir use in Europe.

The clinical experience in Norway and elsewhere suggests that people who become ill with an oseltamivir resistant strain of Influenza A(H1N1) had a similar spectrum of illness to those infected with ‘normal’ seasonal influenza A, which can cause severe disease or death in vulnerable people (older people, those with debilitating illnesses and the very young).

At this stage the significance of these findings remains uncertain. The emergence of drug resistance in the context of limited drug use is unexpected, and the extent of future circulation is difficult to predict. The ECDC, WHO, European Influenza Surveillance Scheme (EISS), European Surveillance Network for Vigilance against Viral Resistance (VIRGIL) and authorities in the member states are undertaking intensive surveillance to monitor this.

Additional Info

  • TheSynapse Magazines: 2008
Read 2875 times Last modified on Saturday, 19 November 2016 23:23


  • WASP - Writing A Scientific Paper

    Quantitative Statistical Analysis
    3-5th April 2019 @ Malta Life Sciences Park
    San Gwann, Malta
    Endorsed by EBCOG and MIPS

    The Write a Scientific Paper (WASP) is an intensive 3 day course that covers all aspects pertaining to writing a scientific paper: from proposal to data protection, data gathering, analysis, writing, dealing with editors and presenting one's research. WASP's uniqueness is its breadth, particularly the statistical analysis sections which are explained in an extremely simple manner.

    Written on December 21, 2018

    A new vacancy has arisen within the Healthcare Division of the Company for a Full Time Medical Representative. Click here for more information.

    Written on December 12, 2018


Connect with other Medical Professionals on fb in a closed facebook group


We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…